Caring Through Science

Providing solutions to the opioid crisis

Caring Through Science

Providing solutions to the opioid crisis

Ocaro Pharmaceuticals is committed to preventing addiction and solving the opioid crisis through science. Our goal is to develop and bring to market a best-in-class opioid-sparing oral drug for post-surgery procedures through a streamlined approach using top scientific partners.

Who We Are

Ocaro Pharmaceuticals is a team of internationally recognized physicians, scientists, and researchers who are using their expertise to develop Ocarocoxib as an opioid-sparing alternative for pain management.

What We Do

Why We Do It

*World Health Organization
**Centers for Disease Control and Prevention and NORC Univ. of Chicago
***Dept. of Health and Human Services

Making an Impact

Opioid overdose in the United States has become an epidemic, killing tens of thousands of people each year. Family relationships and the economy also suffer because of opioid addiction. Ocaro is determined to make an impact by developing a non-addictive opioid alternative – a step toward ending physicians’ reliance on opioids for patients’ post-operative pain relief. 

Over the past several years, Ocaro scientists, all of whom are veteran industry experts with pharmaceutical engineering backgrounds, have been working to develop a post-surgery opioid-sparing drug. With the regulatory oversight of the FDA and support from highly ranked university research centers, Ocaro plans to move into the clinical trial phase and bring this drug to market as soon as possible.  

Making an Impact

Opioid overdose in the United States has become an epidemic, killing tens of thousands of people each year. Family relationships and the economy also suffer because of opioid addiction. Ocaro is determined to make an impact by developing a non-addictive opioid alternative – a step toward ending physicians’ reliance on opioids for patients’ post-operative pain relief.

Over the past several years, Ocaro scientists, all of whom are veteran industry experts with pharmaceutical engineering backgrounds, have been working to develop a post-surgery opioid-sparing drug. With the regulatory oversight of the FDA and support from highly ranked university research centers, Ocaro plans to move into the clinical trial phase and bring this drug to market as soon as possible.

Need help? Call our award-winning support team at (XXX) XXX-XXX

Copyright 2024 © All Rights Reserved.